Ameloblastoma medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Simrat Sarai (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Ameloblastoma}} | {{Ameloblastoma}} | ||
{{CMG}} | {{CMG}}{{AE}}{{Simrat}} | ||
==Overview== | |||
==Medical Therapy== | ==Medical Therapy== | ||
Ameloblastomas are relatively resistant to [[chemotherapy]] or [[radiation therapy]], thus [[surgery]] is the most common treatment of this tumor. | Ameloblastomas are relatively resistant to [[chemotherapy]] or [[radiation therapy]], thus [[surgery]] is the most common treatment of this tumor. | ||
Revision as of 18:41, 23 December 2015
|
Ameloblastoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ameloblastoma medical therapy On the Web |
|
American Roentgen Ray Society Images of Ameloblastoma medical therapy |
|
Risk calculators and risk factors for Ameloblastoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]
Overview
Medical Therapy
Ameloblastomas are relatively resistant to chemotherapy or radiation therapy, thus surgery is the most common treatment of this tumor.